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Why no reliable estimate can be produced 
for the rate of return on investment in 
primary prevention of dementia 
A return on investment (ROI) analysis in health and social care would normally focus on 
a specific intervention and would analyse the return on the costs of the intervention from 
the flow of savings and/or monetised benefits accruing from the intervention. The initial 
plan for the Personal Social Services Research Unit (PSSRU) study of primary 
prevention of dementia was that it should include development of an ROI tool. This 
would enable local commissioners to estimate the return they could expect from 
investment in specific primary prevention interventions in mid-life to prevent, or reduce, 
subsequent onset of dementia later in life. 
 
The research team planned to design and produce a user-friendly modelling tool to 
assist local areas to determine their population/need-specific primary prevention 
strategy and to quantify the dementia-specific return on investment of a given initiative 
in a local area. PHE asked the researchers to focus on primary prevention and not 
extend this project to secondary prevention. 
 
We were not able to find, through our extensive literature review, any studies of the 
effectiveness or cost-effectiveness of primary prevention interventions relating to 
dementia. For example, a recent review of past and current interventions for dementia 
and cognitive decline did not list any trials that focused on health-related behaviours in 
midlife and reported results on dementia as an outcome (1). It is not surprising that 
evaluations have not been conducted for such interventions. They would require 
following up both treatment and control arms of the study for at least 25 years and 
preferably rather longer. 
 
A long follow-up is necessary because the focus of primary prevention of dementia 
needs to be on risk factors in midlife (ages 40 to 64). Although dementia is typically 
developed in very late life, the processes leading to precursory health problems often 
start in mid-life.  
 
In the absence of studies of the effectiveness of primary prevention interventions 
relating to dementia, we discussed use of a two-step process with the project Steering 
Group. This involved linking: (a) the findings of one or more evaluations of a specific 
intervention and its impact on (for example) participation in physical activity, and (b) the 
findings of other studies which explored the relationship between participation in 
physical activity and onset of dementia years later. 
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However, the two example analyses we produced were considered by the Steering 
Group as well as by ourselves to be unreliable. It was not possible to be confident that 
the evaluation of the intervention and the study of the risk factor for dementia were 
compatible. For the process to be reliable there would need to be compatibility in terms 
of the characteristics of those offered the intervention (especially age, health status), the 
nature of the intervention (eg exercise class), the definition of the outcome of the 
intervention (eg 20 minutes of moderate exercise five times per week), and the duration 
of participation in the intervention (eg exercise maintained over at least ten years).  
 
In theory, one way forward could be to commission an evaluation of an intervention 
whose findings could be linked with the findings of an existing study of the impact on 
incidence of dementia in old age of the risk factor(s) to which the intervention relates. 
An issue is whether this would be sufficiently reliable to justify the cost of the evaluation. 
It is very doubtful that a tool developed through such a two-step approach would be 
regarded as robust as a tool based on direct evidence of the impact of an intervention 
on incidence of dementia. 
 
We then suggested, following discussion with experts and with PHE, that we aim to 
produce a different form of tool. It would focus on the link between behaviours and 
conditions in mid-life and dementia onset in later life. It would present for individual 
areas an estimate of the current and projected future prevalence of dementia under 
current arrangements and under alternatives involving primary prevention. It became 
clear, however, that this too presented problems. 
 
We discussed with the Steering Group the development of a form of ‘ready reckoner’ 
indicating the possible impact of changes in risk factors on numbers of older people with 
dementia in the future. Users of the tool would be enabled to enter their local objectives, 
eg 100 people in mid-life successfully enabled to give up smoking or take up physical 
activity (of given intensity) and continue it for an extended period. The tool would then 
provide an estimate of the proportion of this group who would be expected to 
experience onset of dementia in the future if they continued smoking or being 
sedentary, and if they gave up smoking or took up and sustained physical activity. 
 
This again presented a range of challenges. First, the evidence on the association 
between risk factors in mid-life and subsequent dementia in old age has limitations; and 
estimates of relative risk, odds ratios and hazard rates are subject to wide confidence 
intervals, see our focused review (2). The tool could in principle have shown a range 
rather than a point estimate, but the range would have been wide. Wide confidence 
intervals are common in population based heterogeneous samples with long follow-up 
periods. A way to reduce the confidence intervals would be to conduct a new study with 
a substantially larger sample. 
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Second, there will be no/negligible effect of changes in mid-life on onset of dementia for 
many years and the biggest impact will occur after 2040 even from smoking cessation 
or commencement of physical activity in 2016. It seemed unlikely, in view of the 
comments we received in our discussions with commissioners, that projected impacts 
so far in the future would be of great interest or value.  
 
Third, there are associations between the different risk factors: For example, smokers 
may be more likely than non-smokers to display other risk factors. This means that, if 
smokers gave up smoking but did not change other risk factors associated with 
smoking, their risk of dementia would not decline as much as suggested by relative risk 
estimates from observational studies. 
 
The tool would have needed to use adjusted relative risk estimates which for some risk 
factors could be calculated using findings from existing studies but would need to be 
estimated for other risk factors. Norton et al (3) examine the association between a 
group of seven risk factors – diabetes, midlife hypertension, midlife obesity, physical 
inactivity, depression, smoking and low educational attainment - and present adjusted 
population-attributable risk estimates for them. We are not aware of similar analyses for 
any other risk factors. 
 
Fourth, changes in smoking, physical activity and other risk factors affect future 
mortality rates as well as future incidence rates for dementia. Modelling in other studies 
- see (4) and our explorative modelling, suggested that people who give up smoking in 
mid-life increase their lifetime risk of dementia despite experiencing reduced 
age-specific incidence of dementia. A tool should ideally reflect this, but this would have 
required further detailed modelling which would have had considerable caveats.  
 
While PHE found that that there is demand among commissioners for a tool that would 
support them identifying quick and reliable wins, there cannot be quick wins from 
primary prevention of dementia and there is insufficient evidence for reliability. We 
found a lack of obvious demand for a tool among the commissioners we consulted. 
This was on the basis that the tool would inevitably show that returns on investment 
would not be achieved for some 25 years and would inevitably be subject to wide 
uncertainty. 
 
The Steering Group agreed with us that it would not be useful to proceed to prepare a 
tool in view of all these challenges. Experts advised that a tool would inevitably be 
unreliable, such that it would not be wise to use it or advocate its use.  
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